Beijing Tiantan Biological Products Co., Ltd. (600161.SS) SHH

Currency In CNY

AD

Valuation

Market Cap32.31B
Enterprise Value30.51B
P/E Ratio31.41
PEG Ratio-0.67
Price/Sales Ratio4.26
Price/Book Ratio2
Enterprise/Revenue3.91
Enterprise/EBITDA13.25

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.13
Operating Margin0.23
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.06

Income Statement

Revenue6.14B
Revenue/Share2.84
Gross Profit2.58B
EBITDA2.29B
Net Income1.09B
Diluted EPS0.55

Balance Sheet

Total Cash2.17B
Total Cash/Share1.1
Total Debt168.42M
Total Debt/Equity0.01
Current Ratio6.98
Book Value Per Share7.9

Price History

52-Week Change-36.32
52-Week High19.38
52-Week Low11.12
Moving Average 50 Days12.44
Moving Average 200 Days14.3

Statistics

Average Volume14.38M
Shares Outstanding1.98B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield1.24
Payout Ratio0.65
Last Split Factor6:5
Last Split DateJune 20, 2024
AD